CANCER MARKER 
 HPV GENOTYPING 
   
   
   

PRODUCT FEATURES

  • 9 tumor markers, 20ul sample, one test
  • Reduce cost up to 30%, Labor saving up to 50%
  • Uniquely designed HAMA effect indication system
  • Growing menu available in the fields of tumor marker
  • Provide 100 times greater confidence than ELISA&IFA
  • Customer tailored flexible tumor markers assembly platform
  • No wash, No sample dilution, directly testable simple assay protocol
  • Selectively analysis and flexible result reporting for individual tumor marker

     

    PATENTED TELLGEN TECHNOLOGY

    CHINA PATENT OFFICE
    Innovative simultaneous multiple tumor markers testing method
    PN: 2004100542571
    Unique HOOK effect indication method
    PN: 200510026872.6
    Unique HAMA effect indication method
    PN: 200510027165.9

    PATENT COOPERATION TREATY (PCT)
    Innovative simultaneous multiple tumor marker testing and interference indication method
    PN: CN2005/001409

    I. HOOK EFFECT
    NO HOOK EFFECT HAS BEEN NOTICED FOR NINE TUMOR MARKERS UP TO VALUE SHOWN

     

    II. REPRODUCIBILITY
    It was determined by calculating 3 different TELLGEN  Multiple Tumor Markers CBA KIT batches: within-run CV<15%, within batch CV<20%.

    TAILORED KITS

    TELLGENMULTIPLE TUMOR MARKERS CBA KITis first flexible open platform for multiple tumor marker diagnostic purpose. Within our 9 most common tumor markers, customer tailored diversified assembly of tumor markers product is available from TELLGEN

    CURRENTLY AVAILABLE PRODUCTS
    1) TELLGENMultiple Tumor Markers CBA KIT
       (AFP, CEA , CA125, NSE, CYFRA21-1, Free PSA, Total PSA, Free β-HCG, CA242)
    2) TELLGEN
    Digestive-TuMarker CBA KIT
        (AFP, CEA, CA125, CYFRA21-1, CA242)

    3) TELLGEN
    Lung-TuMarker CBA KIT
        (CYFRA21-1, CEA, NSE, CA125)

    4) TELLGEN
    Gynecology-TuMarker CBA KIT
        (AFP, CEA, CA125, Free β-HCG, CYFRA21-1)

    5) TELLGEN
    PSA CBA KIT
        (Free PSA, Total PSA)

    6) TELLGEN
    SINGLE TUMER MARKER KIT
       (AFP, CEA , CA125, NSE, CYFRA21-1, Free PSA, Total PSA, Free β-HCG, CA242)

    ASSAY PRINCIPLE

     

    TECHNICAL PLATFORM

    Multiple Tumor Markers Immunoassay Test Kits based on Flow Cytometry with special software technology platform. Different sizes(4.5-7um)or colors microspheres was coated with a reagent specific to a particular bioassay, allowing the capture and detection of specific analytes from a sample. The Cytometric Bead Array(CBA) system analyzes immunoassays, complex genetic analyses, and enzymatic assays in one simple format. The reactants (antibodies, oligonucleotides, substrate, etc) of these assays are anchored to the surface of uniquely fluorescent microscopic beads. The unique fluorescent emission spectra of a given microsphere, identifies each of the assays performed simultaneously on a single sample. The CBA system individually analyzes microspheres in a flow stream. Every microsphere is accurately classified to its own subset, based on its fluorescent signature. In addition, the Cytometry scans each bead for the presence of a reporter fluorescent that qualities the assay at the bead's surface

  • Distinguishable microsphere set is conjugated to a different antibody making it possible for the system to identify mixed microsphere sets.
  • Different microsphere sets are mixed together in a single well to create a multiplexed assay capable of simultaneously analyzing a single specimen for up to lots of multiple analytes.
  • As the microspheres in a fluid stream pass through the instrument's two laser beams, high-speed digital signal processors and computer algorithms distinguish which assay is being carried on each bead. It quantitates the reaction based on fluorescent reporter signals.
  • Using CBA system, reactions are read on every microsphere at a rate of up to 20,000 microspheres per second.


    ORDERING INFORMATION

    96 well plate : LP010010
    48 well plate : LP010011

     

  •    LINKS
    © 2005 TELLGEN LIFE SCIENCE Corporation. All rights reserved.